15-44651559-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_025137.4(SPG11):ā€‹c.1388T>Cā€‹(p.Phe463Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.454 in 1,613,660 control chromosomes in the GnomAD database, including 167,750 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.48 ( 17741 hom., cov: 32)
Exomes š‘“: 0.45 ( 150009 hom. )

Consequence

SPG11
NM_025137.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 1.39
Variant links:
Genes affected
SPG11 (HGNC:11226): (SPG11 vesicle trafficking associated, spatacsin) The protein encoded by this gene is a potential transmembrane protein that is phosphorylated upon DNA damage. Defects in this gene are a cause of spastic paraplegia type 11 (SPG11). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.9492717E-4).
BP6
Variant 15-44651559-A-G is Benign according to our data. Variant chr15-44651559-A-G is described in ClinVar as [Benign]. Clinvar id is 41271.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-44651559-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.534 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SPG11NM_025137.4 linkuse as main transcriptc.1388T>C p.Phe463Ser missense_variant 6/40 ENST00000261866.12 NP_079413.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SPG11ENST00000261866.12 linkuse as main transcriptc.1388T>C p.Phe463Ser missense_variant 6/401 NM_025137.4 ENSP00000261866.7 Q96JI7-1

Frequencies

GnomAD3 genomes
AF:
0.481
AC:
73026
AN:
151916
Hom.:
17722
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.524
Gnomad AMI
AF:
0.595
Gnomad AMR
AF:
0.543
Gnomad ASJ
AF:
0.465
Gnomad EAS
AF:
0.482
Gnomad SAS
AF:
0.368
Gnomad FIN
AF:
0.481
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.448
Gnomad OTH
AF:
0.473
GnomAD3 exomes
AF:
0.468
AC:
117565
AN:
251374
Hom.:
28019
AF XY:
0.458
AC XY:
62202
AN XY:
135856
show subpopulations
Gnomad AFR exome
AF:
0.528
Gnomad AMR exome
AF:
0.568
Gnomad ASJ exome
AF:
0.462
Gnomad EAS exome
AF:
0.456
Gnomad SAS exome
AF:
0.371
Gnomad FIN exome
AF:
0.482
Gnomad NFE exome
AF:
0.454
Gnomad OTH exome
AF:
0.469
GnomAD4 exome
AF:
0.451
AC:
659493
AN:
1461626
Hom.:
150009
Cov.:
52
AF XY:
0.449
AC XY:
326424
AN XY:
727136
show subpopulations
Gnomad4 AFR exome
AF:
0.524
Gnomad4 AMR exome
AF:
0.569
Gnomad4 ASJ exome
AF:
0.464
Gnomad4 EAS exome
AF:
0.541
Gnomad4 SAS exome
AF:
0.368
Gnomad4 FIN exome
AF:
0.492
Gnomad4 NFE exome
AF:
0.446
Gnomad4 OTH exome
AF:
0.450
GnomAD4 genome
AF:
0.481
AC:
73084
AN:
152034
Hom.:
17741
Cov.:
32
AF XY:
0.480
AC XY:
35695
AN XY:
74320
show subpopulations
Gnomad4 AFR
AF:
0.523
Gnomad4 AMR
AF:
0.543
Gnomad4 ASJ
AF:
0.465
Gnomad4 EAS
AF:
0.482
Gnomad4 SAS
AF:
0.367
Gnomad4 FIN
AF:
0.481
Gnomad4 NFE
AF:
0.448
Gnomad4 OTH
AF:
0.473
Alfa
AF:
0.454
Hom.:
40099
Bravo
AF:
0.490
TwinsUK
AF:
0.437
AC:
1622
ALSPAC
AF:
0.435
AC:
1678
ESP6500AA
AF:
0.525
AC:
2310
ESP6500EA
AF:
0.456
AC:
3917
ExAC
AF:
0.466
AC:
56539
Asia WGS
AF:
0.462
AC:
1607
AN:
3478
EpiCase
AF:
0.445
EpiControl
AF:
0.454

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 11 Benign:7
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical CenterApr 22, 2016- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 13, 2017- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou Lab-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not specified Benign:4
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 21, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Hereditary spastic paraplegia Benign:1
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenDec 12, 2016- -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Amyotrophic lateral sclerosis type 5 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou Lab-- -
Charcot-Marie-Tooth disease axonal type 2X Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou Lab-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
18
DANN
Benign
0.96
DEOGEN2
Benign
0.039
T;.;T;.;.
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.26
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.81
T;T;T;T;T
MetaRNN
Benign
0.00049
T;T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Uncertain
2.1
M;M;.;M;.
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-1.3
N;N;N;N;N
REVEL
Benign
0.18
Sift
Benign
0.34
T;T;T;T;T
Sift4G
Benign
0.33
T;T;T;T;T
Polyphen
0.021
B;.;B;.;.
Vest4
0.20
MPC
0.30
ClinPred
0.016
T
GERP RS
4.9
Varity_R
0.096
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3759871; hg19: chr15-44943757; COSMIC: COSV55992310; API